An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Clinical trial NCT01739348 · TERMINATED
Trial details
- NCT number
- NCT01739348
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-30
- Primary completion
- 2017-04-14
- Enrollment
- 2211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.